CHL · Class II · 21 CFR 862.1120

FDA Product Code CHL: Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

Leading manufacturers include Abbott Point of Care, Inc., Radiometer Medicals Aps and Nova Biomedical Corporation.

188
Total
188
Cleared
103d
Avg days
1976
Since
Declining activity - 3 submissions in the last 2 years vs 5 in the prior period
Review times increasing: avg 214d recently vs 101d historically

FDA 510(k) Cleared Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph Devices (Product Code CHL)

188 devices
1–24 of 188

About Product Code CHL - Regulatory Context

510(k) Submission Activity

188 total 510(k) submissions under product code CHL since 1976, with 188 receiving FDA clearance (average review time: 103 days).

Submission volume has declined in recent years - 3 submissions in the last 24 months compared to 5 in the prior period.

FDA Review Time

Recent submissions under CHL have taken an average of 214 days to reach a decision - up from 101 days historically. Manufacturers should account for longer review timelines in current project planning.

CHL devices are reviewed by the Chemistry panel. Browse all Chemistry devices →